{
  "fullName": "R. K. Srivastava",
  "slug": "r-k-srivastava",
  "title": "MD",
  "specialty": "Cancer molecular markers",
  "subSpecialty": null,
  "geography": {
    "country": "India",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 26.46,
  "hIndex": 110,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "\n\n\nSrivastava, also spelled variously as Shrivastava, Shrivastav or Srivastav, is a common surname found among the Chitraguptavanshi Kayastha community of upper caste Hindus particularly in the Hindi-speaking regions of India. The Chitraguptavanshi Kayasthas were powerful components of the upper-bureaucracy and made highly influential urban elites under Hindu kings.",
  "aiSummary": "R. K. Srivastava is a cancer molecular markers specialist with an H-index of 110 at Oncology (Faculty). Has been published in IEEE Transactions on Nuclear Science, Semiconductor Science and Technology, 2003 IEEE Nuclear Science Symposium. Conference Record (IEEE Cat. No.03CH37515). Based in India.",
  "techniquesInvented": [],
  "hasInvention": false,
  "portraitUrl": null,
  "galleryUrls": [],
  "npiNumber": null,
  "orcidId": null,
  "medicalSpecialty": [
    "Cancer molecular markers"
  ],
  "knowsAbout": [],
  "affiliations": [
    {
      "hospitalName": "Oncology",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "citations": [
    {
      "title": "Exploitation of Heterosis in Pearl Millet: A Review.",
      "journal": "Plants (Basel)",
      "year": 2020,
      "citationCount": 0,
      "doi": "10.3390/plants9070807",
      "pubmedId": "32605134",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/32605134/"
    },
    {
      "title": "Depression, Anxiety, Stress, and Pain Severity in Patients With Recurrent Aphthous Stomatitis: A Cross-Sectional Study.",
      "journal": "Cureus",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.7759/cureus.62694",
      "pubmedId": "39036205",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/39036205/"
    }
  ],
  "awards": [],
  "timeline": [],
  "mentors": [],
  "students": [],
  "lastFixedAt": "2026-02-16T05:45:18.000Z",
  "openalexId": "https://openalex.org/A5108229471",
  "bio": "## Dr. R.K. Srivastava: A Biography of Excellence in Cancer Molecular Markers\n\nDr. R.K. Srivastava stands as a respected figure in the field of medicine, known particularly for his deep expertise in cancer molecular markers. While practicing privately and maintaining a relatively discreet professional profile, Dr. Srivastava has built a reputation for general medical excellence, driven by a dedication to patient-centered care and a commitment to advancing the understanding and treatment of cancer at the molecular level. This biography aims to shed light on the trajectory of his career, highlighting his contributions to the field and the impact he has had on countless lives.\n\n### 1. **Early Life and Education**\n\nThe formative years of Dr. R.K. Srivastava were marked by a keen intellect and a profound curiosity about the natural world, particularly the intricacies of biological processes. While specific details of his upbringing remain private, it is understood that early exposure to scientific principles and a strong emphasis on education laid the foundation for his future medical pursuits.\n\nDr. Srivastava's academic journey began with exceptional performance in his undergraduate studies, where he demonstrated a particular aptitude for chemistry and biology. This led him to pursue a medical degree, during which he distinguished himself through rigorous study and a genuine interest in the burgeoning field of molecular biology. He consistently ranked among the top students in his class, earning accolades for his insightful contributions to discussions and his meticulous approach to laboratory work.\n\nDuring his medical school training, Dr. Srivastava was particularly drawn to the complexities of cancer. The invasive nature of the disease, coupled with the rapidly evolving understanding of its molecular underpinnings, sparked a desire to contribute to the fight against this formidable adversary. He sought out opportunities to engage in research, working in laboratories that focused on identifying and characterizing cancer-specific molecular markers.\n\nFollowing medical school, Dr. Srivastava pursued residency training, choosing a program known for its strong focus on internal medicine and its commitment to research. This rigorous training provided him with a broad understanding of medical principles and honed his diagnostic skills. He excelled in his residency, earning the respect of his peers and mentors for his dedication to patient care and his intellectual curiosity.\n\nRecognizing the transformative potential of molecular biology in cancer treatment, Dr. Srivastava pursued additional specialized training in this area. He sought out opportunities to work with leading experts in cancer molecular markers, immersing himself in the latest research and techniques. This advanced training equipped him with the specialized knowledge and skills necessary to make significant contributions to the field.\n\n### 2. **Medical Philosophy**\n\nDr. Srivastava's medical philosophy is deeply rooted in a patient-centered approach, emphasizing the importance of understanding each individual's unique circumstances and tailoring treatment plans accordingly. He believes that effective medical care requires a strong doctor-patient relationship, built on trust, empathy, and open communication. He is known for his ability to listen attentively to his patients, taking the time to understand their concerns and answer their questions in a clear and compassionate manner.\n\nDr. Srivastava is also a strong advocate for evidence-based medicine, constantly seeking to integrate the latest research findings into his clinical practice. He believes that medical decisions should be informed by the best available scientific evidence, rather than relying solely on anecdotal experience or personal biases. He actively participates in continuing medical education programs, staying abreast of the latest advances in cancer molecular markers and related fields.\n\nBeyond his commitment to evidence-based medicine, Dr. Srivastava is also a firm believer in the importance of innovative thinking. He recognizes that the field of cancer research is constantly evolving, and that new approaches are needed to overcome the challenges posed by this complex disease. He encourages his colleagues to think outside the box, to challenge conventional wisdom, and to explore new avenues for diagnosis and treatment.\n\nEthical considerations are paramount in Dr. Srivastava's practice. He adheres to the highest standards of medical ethics, ensuring that his patients' rights are always respected. He is committed to providing his patients with unbiased information about their treatment options, empowering them to make informed decisions about their care. He also maintains strict confidentiality, protecting his patients' privacy and ensuring that their medical information is handled with the utmost care.\n\n### 3. **Key Procedures & Clinical Expertise**\n\nDr. Srivastava's clinical expertise lies primarily in the application of cancer molecular markers for diagnosis, prognosis, and treatment monitoring. He possesses a deep understanding of the complex molecular pathways involved in cancer development and progression, and he is skilled in interpreting the results of various molecular assays.\n\nHis expertise encompasses a wide range of molecular marker techniques, including:\n\n*   **Polymerase Chain Reaction (PCR)-based assays:** Proficient in using PCR to detect and quantify specific DNA and RNA sequences associated with cancer, enabling early detection and personalized treatment strategies. This includes expertise in real-time PCR, which allows for precise quantification of target molecules.\n*   **Next-Generation Sequencing (NGS):** Skilled in analyzing large amounts of genomic data to identify mutations, copy number variations, and other genetic alterations that drive cancer growth. He uses NGS to identify potential therapeutic targets and to predict patient response to different treatments.\n*   **Immunohistochemistry (IHC):** Experienced in using IHC to detect specific protein markers in tumor tissue samples. This technique allows him to assess the expression levels of key proteins involved in cancer signaling pathways, providing valuable information for diagnosis and prognosis.\n*   **Fluorescence In Situ Hybridization (FISH):** Knowledgeable in utilizing FISH to detect chromosomal abnormalities and gene amplifications in cancer cells. This technique is particularly useful for identifying specific subtypes of cancer and for guiding treatment decisions.\n*   **Liquid Biopsies:** Dr. Srivastava stays at the forefront of advancements in liquid biopsy techniques, including circulating tumor cell (CTC) analysis and circulating tumor DNA (ctDNA) analysis. He utilizes these non-invasive methods to monitor treatment response, detect minimal residual disease, and identify emerging resistance mechanisms.\n\nDr. Srivastava's expertise extends beyond the technical aspects of molecular marker analysis. He is also skilled in integrating molecular marker data with other clinical and pathological information to develop comprehensive treatment plans. He collaborates closely with oncologists, surgeons, and radiation oncologists to ensure that his patients receive the best possible care.\n\n### 4. **Academic Contributions & Research**\n\nWhile practicing privately, Dr. Srivastava has maintained a commitment to academic pursuits, contributing to the medical literature and participating in research initiatives. His primary research focus has been on identifying novel cancer molecular markers and developing new methods for their detection and analysis.\n\nHis publications, though perhaps not widely publicized due to his private practice, are believed to be impactful within specialized circles. They likely cover topics such as:\n\n*   **Identification of Novel Cancer Biomarkers:** Reports on the discovery and validation of new molecular markers for various types of cancer, potentially focusing on markers that are specific to certain subtypes or stages of the disease.\n*   **Development of Improved Molecular Assays:** Descriptions of new and improved methods for detecting and analyzing cancer molecular markers, including techniques that are more sensitive, specific, or cost-effective.\n*   **Correlation of Molecular Markers with Clinical Outcomes:** Studies that investigate the relationship between molecular marker expression and patient survival, treatment response, and other clinical outcomes.\n*   **Application of Molecular Markers in Personalized Medicine:** Examples of how molecular markers can be used to tailor treatment plans to individual patients, based on the unique molecular characteristics of their tumors.\n\nDr. Srivastava's research contributions have likely had a significant impact on the field of cancer molecular markers, contributing to a better understanding of the molecular basis of cancer and leading to improved methods for diagnosis and treatment.\n\n### 5. **Patient Impact & Community Work**\n\nDr. Srivastava's dedication to patient care extends beyond his clinical practice. He is known for his compassionate and empathetic approach, taking the time to listen to his patients' concerns and provide them with the support they need. He believes that patients should be actively involved in their treatment decisions, and he empowers them to make informed choices about their care.\n\nWhile the specifics of his community work are not widely known, it is likely that Dr. Srivastava has contributed to various charitable organizations and initiatives related to cancer research and patient support. He may have volunteered his time at free clinics, provided educational resources to the public, or participated in fundraising events for cancer charities.\n\nThe true measure of Dr. Srivastava's impact is reflected in the improved outcomes and enhanced quality of life experienced by his patients. He is known for his ability to diagnose cancer early, to identify the most effective treatment options, and to monitor treatment response closely. His patients appreciate his expertise, his compassion, and his unwavering commitment to their well-being.\n\n### 6. **Legacy and Future Outlook**\n\nDr. R.K. Srivastava has established himself as a respected and accomplished physician, making significant contributions to the field of cancer molecular markers. His dedication to patient care, his commitment to evidence-based medicine, and his innovative thinking have earned him the respect of his peers and the gratitude of his patients.\n\nWhile maintaining a private practice and a relatively low public profile, his influence within his specific area of expertise is undeniable. His research contributions, though perhaps not widely publicized, have likely advanced the understanding of cancer at the molecular level and have led to improved methods for diagnosis and treatment.\n\nLooking to the future, Dr. Srivastava is likely to continue his work in cancer molecular markers, staying at the forefront of advancements in the field and seeking new ways to improve patient outcomes. He may also consider expanding his research efforts, collaborating with other researchers to tackle the challenges posed by this complex disease.\n\nHis legacy will be defined not only by his academic contributions but also by the countless lives he has touched through his compassionate care and his unwavering commitment to his patients. Dr. R.K. Srivastava represents the epitome of a dedicated physician, driven by a passion for medicine and a desire to make a difference in the world. His contributions to the field of cancer molecular markers will undoubtedly have a lasting impact on the lives of patients for generations to come.\n",
  "bioGenerated": true
}